Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of obesity. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://matheswlb203979.laowaiblog.com/37751410/retaglutide-a-promising-glp-1-receptor-agonist